HOUSE OF REPRESENTATIVESSENATEExecutive Office of the President (EOP)Health & Human Services, Dept of (HHS)
Specific issues
General Medicare and Medicaid Issues.
Medicare/Medicaid · 2026 Q1
Prescription drug payment reform. Pharmaceutical Supply Chain.
Pharmacy · 2026 Q1
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.
Health Issues · 2026 Q1
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.
Pharmacy · 2026 Q1
Issues related to USTR/trade.
Trade (domestic/foreign) · 2026 Q1
Pharmaceutical Supply Chain. H.R.2213: Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832: EPIC Act of 2025.